Tuesday, November 17, 2026

The serious complications of GLP-1s that few may know about

 https://www.washingtonpost.com/health/2026/11/16/glp-1-weight-loss-drugs-have-big-cons-even-if-serious-problems-are-rare/?utm_source=email&utm_medium=acq&utm_campaign=RH-ACQ&utm_content=dtpannual_20261116_RH&campaign_id=21071236

Four months after Engel started taking Ozempic to treat his diabetes, he woke one morning unable to see out of his right eye. His ophthalmologist told him the damage was permanent but couldn’t explain what caused it. No one suggested Ozempic might be involved, so Engel kept taking the GLP-1 drug.

For millions of patients, GLP-1 drugs have been safe and effective, delivering important health benefits for those struggling with obesity, diabetes, heart disease and more. But with many millions of people taking the drugs, some uncommon problems are coming to light.

There is no evidence of a broad eye-safety problem with the use of GLP-1s, a counterpoint to the rare but serious issues like Engel’s. A 2026 study involving 5.5 million people found use of the drugs was associated with a lower incidence of macular degeneration. While the lack of evidence can’t prove the drugs are protective, it adds another layer of complexity to how people should think about them.

No comments :

Post a Comment

ANONYMOUS COMMENTS WILL NOT BE POSTED!
please use either your real name or a pseudonym.